https://clinicaltrials.gov/ct2/show/NCT03912233?recrs=abdf&type=Intr&cond=Cystic+Fibrosis&lupd_s=03%2F28%2F2019&lupd_d=14
Condition : Cystic Fibrosis
Interventions : Drug: VX-121; Drug: TEZ; Drug: VX-561; Drug: TEZ/IVA; Drug: IVA; Drug: Placebo
Sponsor : Vertex Pharmaceuticals Incorporated
Not yet recruiting
A Study to Evaluate the Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis
NCT03912233
Thu, 11 Apr 2019 12:00:00 EDT
Last Update Posted: 04/11/19 08:16AM
